Many patients endure hours-long infusions because antibody doses can exceed 100 milliliters, far beyond subcutaneous limits ...

The company’s first-in-class and potential best-in-class therapeutics promise to be both effective and organ-protective and ...

Explore The Innovation Antibody and how organizational resistance can kill innovation from within, undermining growth, ...

Just-Evotec Biologics receives Gates Foundation grant for AI-driven optimization of monoclonal antibody developability for affordable access: Hamburg, Germany Saturday, January 10 ...

The collaboration builds on the internal strengths of Bayer in antibody design, synthesis and machine learning, complementing ...

Partnership has already generated high-quality, AI-ready data in less than three months MOUNTAIN VIEW, CA / ACCESS Newswire / January 8, 2026 / AbTherx today announced a therapeutic antibody discovery ...

Orum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Chad May, Ph.D., as Chief ...

As of Friday, January 09, Quanterix Corporation’s QTRX share price has surged by 18.97%, which has investors questioning if ...

Participants with prior infection were more likely than vaccine recipients to retain some detectable antibodies.

The market is defying broader economic headwinds through a structural pivot toward high-complexity outsourcing. While general ...

Just - Evotec Biologics will optimize monoclonal antibodies ("mAbs") and other biologic modalitiesInvestment enables ten new J.MD projects encompassing molecular optimization including, but not limite ...

At the end of last year, an Ebola disease outbreak in the Democratic Republic of Congo’s Kasai province was officially declared over.